Skip to main content
TipRanks
Go Ultimate75% OFF
TORL BioTherapeutics logo

TORL BioTherapeutics: Valuation, Funding & Investors

TORL BioTherapeutics is a biotechnology company dedicated to the development of targeted therapies for cancer treatment. The company leverages advanced scientific research to create innovative solutions aimed at improving patient outcomes in oncology.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$96M
Total Funding Rounds
1
Latest Funding Amount
$96M
Latest Funding Round
Series C

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 07, 2025Series C$96.00M―

Similar Companies

A snapshot of private companies similar to TORL BioTherapeutics, helping you discover and navigate related company profiles.

Related News and Analysis